{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:53Z","timestamp":1761975413127,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","award":["01025007"],"award-info":[{"award-number":["01025007"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["NS-079678","NS-069847","K23AR055664"],"award-info":[{"award-number":["NS-079678","NS-069847","K23AR055664"]}]}],"content-domain":{"domain":["epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.yebeh.2013.02.029","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T07:00:33Z","timestamp":1365145233000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ezogabine (KCNQ2\/3 channel opener) prevents delayed activation of meningeal nociceptors if given before but not after the occurrence of cortical spreading depression"],"prefix":"10.1016","volume":"28","author":[{"given":"XiChun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Kainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2013.02.029_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1526-4610.1999.3907469.x","article-title":"The occipital cortex is hyperexcitable in migraine: experimental evidence","volume":"39","author":"Aurora","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","article-title":"Spreading depression of activity in cerebral cortex","volume":"7","author":"Leao","year":"1944","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0015","first-page":"363","article-title":"Spreading depression","volume":"1","author":"Leao","year":"1986","journal-title":"Funct Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/brain\/107.2.447","article-title":"Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography","volume":"107","author":"Lauritzen","year":"1984","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.56.5.548","article-title":"Functional MRI-BOLD of visually triggered headache in patients with migraine","volume":"56","author":"Cao","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0030","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.071582498","article-title":"Mechanisms of migraine aura revealed by functional MRI in human visual cortex","volume":"98","author":"Hadjikhani","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","article-title":"Origin of pain in migraine: evidence for peripheral sensitisation","volume":"8","author":"Olesen","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0040","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","article-title":"Activation of meningeal nociceptors by cortical spreading depression: implications to migraine with aura","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.22329","article-title":"Activation of central trigeminovascular neurons by cortical spreading depression","volume":"69","author":"Zhang","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/mol.58.3.591","article-title":"Retigabine, a novel anti-convulsant, enhances activation of KCNQ2\/Q3 potassium channels","volume":"58","author":"Wickenden","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0055","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/mol.58.2.253","article-title":"Modulation of KCNQ2\/3 potassium channels by the novel anticonvulsant retigabine","volume":"58","author":"Main","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nurt.2007.01.013","article-title":"Ion channel pharmacology","volume":"4","author":"Camerino","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0733-8619(05)70297-8","article-title":"Migraine and epilepsy","volume":"15","author":"Welch","year":"1997","journal-title":"Neurol Clin"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10194-011-0318-4","article-title":"Migralepsy, hemicrania epileptica, post-ictal headache and \u201cictal epileptic headache\u201d: a proposal for terminology and classification revision","volume":"12","author":"Belcastro","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0080","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1528-1167.2005.00344.x","article-title":"Somatic comorbidity of epilepsy in the general population in Canada","volume":"46","author":"Tellez-Zenteno","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(06)70348-9","article-title":"Chronic disorders with episodic manifestations: focus on epilepsy and migraine","volume":"5","author":"Haut","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jnr.20498","article-title":"Intrinsic excitability, synaptic potentials, and short-term plasticity in human epileptic neocortex","volume":"80","author":"Koch","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0095","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1038\/399a015","article-title":"Emerging insights into the genesis of epilepsy","volume":"399","author":"McNamara","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0100","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1468-2982.2007.01502.x","article-title":"The brain is hyperexcitable in migraine","volume":"27","author":"Aurora","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1468-2982.2007.01500.x","article-title":"Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?","volume":"27","author":"Coppola","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1146\/annurev.physiol.61.1.835","article-title":"Ion channels of nociception","volume":"61","author":"McCleskey","year":"1999","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.59.1.483","article-title":"Control of M-current","volume":"59","author":"Marrion","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0120","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0125","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origin of headaches","volume":"384","author":"Strassman","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0130","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","article-title":"Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine","volume":"58","author":"Levy","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/brain\/117.1.199","article-title":"Pathophysiology of the migraine aura. The spreading depression theory","volume":"117","author":"Lauritzen","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1212\/WNL.47.4.918","article-title":"Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility?","volume":"47","author":"Ottman","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0145","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0150","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1152\/jn.91339.2008","article-title":"Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators","volume":"101","author":"Harriott","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0155","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.wnl.0000259034.45049.00","article-title":"Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures","volume":"68","author":"Porter","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00912700222011210","article-title":"Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers","volume":"42","author":"Ferron","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1528-1167.2011.03364.x","article-title":"The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use","volume":"53","author":"Large","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.eplepsyres.2006.02.001","article-title":"Seizure anticipation by patients with focal and generalized epilepsy: a multicentre assessment of premonitory symptoms","volume":"70","author":"Schulze-Bonhage","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.seizure.2004.11.002","article-title":"Perceived self-control of seizures in patients with uncontrolled partial epilepsy","volume":"14","author":"Lee","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0180","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1523\/JNEUROSCI.6053-09.2010","article-title":"Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents","volume":"30","author":"Vaughn","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0185","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1523\/JNEUROSCI.21-13-04609.2001","article-title":"Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain","volume":"21","author":"Saganich","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0190","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1523\/JNEUROSCI.14-11-07087.1994","article-title":"Role of neuronal synchronizing mechanisms in the propagation of spreading depression in the in vivo hippocampus","volume":"14","author":"Herreras","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(93)91411-K","article-title":"Propagation of spreading depression among dendrites and somata of the same cell population","volume":"610","author":"Herreras","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0200","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1152\/jn.1975.38.4.822","article-title":"Neuronal and glial activity during spreading depression in cerebral cortex of cat","volume":"38","author":"Sugaya","year":"1975","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0210","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0220","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0225","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1528-1157.1999.tb02029.x","article-title":"The pharmacologic basis of antiepileptic drug action","volume":"40","author":"Rho","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentary","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2013.02.029_bb0235","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1528-1157.2000.tb02166.x","article-title":"Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture","volume":"41","author":"McLean","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0245","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)38047-4","article-title":"Inhibition of transient and persistent Na+current fractions by the new anticonvulsant topiramate","volume":"288","author":"Taverna","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0250","series-title":"Epilepsy: mechanisms, models, and translational perspectives","first-page":"123","article-title":"Mechanisms of antiepileptic drug action","author":"Simeone","year":"2010"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eplepsyres.2011.05.009","article-title":"cAMP-dependent protein kinase A activity modulates topiramate potentiation of GABA(A) receptors","volume":"96","author":"Simeone","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(97)01249-1","article-title":"The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells","volume":"336","author":"Rundfeldt","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2013.02.029_bb0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(03)01426-2","article-title":"Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex","volume":"464","author":"van Rijn","year":"2003","journal-title":"Eur J Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505013001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505013001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:18:08Z","timestamp":1745983088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505013001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1525505013001145"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2013.02.029","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezogabine (KCNQ2\/3 channel opener) prevents delayed activation of meningeal nociceptors if given before but not after the occurrence of cortical spreading depression","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2013.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}